Cardinal making $2.4 bil. move into contract drug manufacturing with R.P. Scherer buy.
This article was originally published in The Tan Sheet
Executive Summary
SCHERER IS CARDINAL ENTRY INTO CONTRACT MANUFACTURING with the wholesaler's addition of 19 production facilities in 12 countries through the $2.4 bil. acquisition of the drug delivery system developer and contract manufacturer R.P. Scherer announced May 18. The agreement will significantly expand Cardinal Health's fledgling contract manufacturing business developed through its PCI and National PharmPak repackaging operations.
You may also be interested in...
Cardinal Adding "Blow-Fill-Seal" Technology With $390 Mil. ALP Purchase
Cardinal Health is adding to its contract manufacturing business with the approximately $390 mil. acquisition of Automatic Liquid Packaging, which manufactures Rx and OTC sterile liquid pharmaceuticals and other health care products. Dublin, Ohio-based Cardinal announced the acquisition agreement with privately held ALP of Woodstock, Ill. Aug. 5.
Cardinal Adding "Blow-Fill-Seal" Technology With $390 Mil. ALP Purchase
Cardinal Health is adding to its contract manufacturing business with the approximately $390 mil. acquisition of Automatic Liquid Packaging, which manufactures Rx and OTC sterile liquid pharmaceuticals and other health care products. Dublin, Ohio-based Cardinal announced the acquisition agreement with privately held ALP of Woodstock, Ill. Aug. 5.
Cardinal Adding "Blow-Fill-Seal" Technology With $390 Mil. ALP Purchase
Cardinal Health is adding to its contract manufacturing business with the approximately $390 mil. acquisition of Automatic Liquid Packaging, which manufactures Rx and OTC sterile liquid pharmaceuticals and other health care products. Dublin, Ohio-based Cardinal announced the acquisition agreement with privately held ALP of Woodstock, Ill. Aug. 5.